Article

Clinical and pathological significance of upregulated RPL32 expression in prostate cancer

2026-06-04

Abstract excerpt

<title>Abstract</title> <p>This study investigates the expression and function of the ribosomal protein L32 (RPL32) gene in prostate cancer (PCa). By integrating data from multiple databases, we found that RPL32 expression is significantly upregulated in PCa tissues, with a potential causal relationship between this upregulation and the risk of developing PCa. The study analyzed PCa-related mRNA data from the GEO...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0455bea9-8b81-5290-90af-2ecf4cd94faf
DOI: 10.21203/rs.3.rs-8931953/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical and pathological significance of upregulated RPL32 expression in prostate cancerDOI 10.21203/rs.3.rs-8931953/v1Read

Construction and Verification of a Prognostic Model for Prostate Cancer based on Ribosome Biogenesis-Related GenesSemantic proximity Read

Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancerSemantic proximity Read

An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancerSemantic proximity Read

Non-Coding RNA Biomarkers in Prostate Cancer: Evidence Mapping and in Silico CharacterizationSemantic proximity Read

Development of a biochemical recurrence prediction model based on pyroptosis related genes in prostate cancerSemantic proximity Read

Ribosomal biogenesis factor, a novel biomarker for predicting progression-free survival in prostate cancerSemantic proximity Read

Evidence from 40 Studies that 2 Common Single-Nucleotide Polymorphisms (SNPs) of RNASEL Gene Affect Prostate Cancer Susceptibility: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-Compliant Meta-Analysis.Semantic proximity Read

SLC25A37 is casually associated with the increased incidence of benign prostatic hyperplasiaSemantic proximity Read

miR-455-3p in peripheral blood is a potentially superior diagnostic marker for prostate cancer to PSASemantic proximity Read

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genesSemantic proximity Read

Preliminary study on miRNA in prostate cancerSemantic proximity Read

Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancerSemantic proximity Read